Developing a New Program to Treat a Rare Pediatric Cancer: Hyperthermic Intraperitoneal Chemotherapy, CRS-HIPEC, in Desmoplastic Small Round Cell Tumor

views

Pediatric Grand Rounds January 17 2017 Andrea Hayes-Jordan, MD, FACS, FAAP Professor in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center

Tags

Developing a New Program to Treat a Rare Pediatric Cancer: Hyperthermic Intraperitoneal Chemotherapy, CRS-HIPEC, in Desmoplastic Small Round Cell Tumor

Related Media